| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.345 | 7.791 | 13.311 | 7.884 | 7.431 | 5.758 | 6.065 | 7.982 | 6.580 | 5.500 |
| Total Income - EUR | 10.345 | 7.791 | 13.311 | 7.884 | 7.431 | 5.758 | 6.065 | 7.982 | 6.580 | 5.500 |
| Total Expenses - EUR | 10.020 | 7.611 | 9.188 | 7.637 | 8.685 | 5.169 | 4.710 | 6.039 | 10.252 | 10.248 |
| Gross Profit/Loss - EUR | 325 | 180 | 4.123 | 247 | -1.255 | 589 | 1.355 | 1.944 | -3.671 | -4.747 |
| Net Profit/Loss - EUR | 14 | 24 | 3.989 | 168 | -1.329 | 439 | 1.189 | 1.826 | -3.734 | -4.912 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Sevado Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.311 | 1.806 | 1.302 | 813 | 342 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 215 | 355 | 5.435 | 5.498 | 4.720 | 5.038 | 6.049 | 8.296 | 4.753 | 112 |
| Inventories | 170 | 344 | 0 | 191 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2 | 2 | 2 | 1 | 75 | 122 | 119 | 85 | 0 | 0 |
| Cash | 43 | 9 | 5.433 | 5.305 | 4.645 | 4.915 | 5.929 | 8.211 | 4.753 | 112 |
| Shareholders Funds | 1.342 | 1.353 | 5.319 | 5.390 | 3.956 | 4.320 | 5.413 | 7.256 | 3.500 | -1.432 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.184 | 809 | 1.417 | 921 | 1.106 | 718 | 636 | 1.041 | 1.253 | 1.544 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Sevado Med Srl